Efficacy of Pneumococcal Vaccine

Ian Hewitt, Edward A. Mortimer, Neal A. Halsey, Frances J. Mather, Arthur J. Ammann, Claire V. Broome, Richard R. Facklam, David W. Fraser

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: The article by Broome et al. in the September 4 issue demonstrates a novel approach to assessing the efficacy of the 14-valent pneumococcal vaccine in the absence of denominators of vaccinated and unvaccinated populations. Unfortunately, the mathematical approach to assessing efficacy, though accurate, is too complex to be understood by most physicians. It could be rephrased in simple, logical terms, as follows. Because it is documented that vaccinated and unvaccinated populations are infected with nonvaccine pneumococcal disease at similar rates (Table 2 of Broome), it is reasonable to assume that, if the vaccine is ineffective, the proportion. . .

Original languageEnglish (US)
Pages (from-to)116-117
Number of pages2
JournalNew England Journal of Medicine
Volume304
Issue number2
DOIs
StatePublished - Jan 8 1981
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Efficacy of Pneumococcal Vaccine'. Together they form a unique fingerprint.

Cite this